Last reviewed · How we verify

Metformin + Janufer (Janumet) — Competitive Intelligence Brief

Metformin + Janufer (Janumet) (Metformin + Janufer (Janumet)) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Biguanide + DPP-4 inhibitor combination. Area: Diabetes.

phase 3 Biguanide + DPP-4 inhibitor combination Metformin: mitochondrial glycerophosphate dehydrogenase; Sitagliptin: DPP-4 enzyme Diabetes Small molecule Live · refreshed every 30 min

Target snapshot

Metformin + Janufer (Janumet) (Metformin + Janufer (Janumet)) — Meir Medical Center. Metformin reduces hepatic glucose production and improves insulin sensitivity, while sitagliptin (Januvia) inhibits DPP-4 to increase incretin-mediated insulin secretion and reduce glucagon.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Metformin + Janufer (Janumet) TARGET Metformin + Janufer (Janumet) Meir Medical Center phase 3 Biguanide + DPP-4 inhibitor combination Metformin: mitochondrial glycerophosphate dehydrogenase; Sitagliptin: DPP-4 enzyme
Metformin and Saxagliptin Metformin and Saxagliptin ikfe-CRO GmbH marketed Biguanide + DPP-4 inhibitor combination Metformin: mitochondrial glycerophosphate dehydrogenase; Saxagliptin: DPP-4 (dipeptidyl peptidase-4)
Metformin plus vildagliptin Metformin plus vildagliptin Sheba Medical Center marketed Biguanide + DPP-4 inhibitor combination Metformin: mitochondrial glycerophosphate dehydrogenase; Vildagliptin: DPP-4 (dipeptidyl peptidase-4)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Biguanide + DPP-4 inhibitor combination class)

  1. Meir Medical Center · 1 drug in this class
  2. Sheba Medical Center · 1 drug in this class
  3. ikfe-CRO GmbH · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Metformin + Janufer (Janumet) — Competitive Intelligence Brief. https://druglandscape.com/ci/metformin-janufer-janumet. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: